Foolish Preview: Gilead Earnings

By Dave Williamson – Jan 31, 2013 at 5:51PM

NASDAQ: GILD

Gilead Sciences

Market Cap

$84B

Today's Change

(0.07%) $0.05

Current Price

$67.08

Price as of April 24, 2024, 4:00 p.m. ET

A look ahead at what we can expect from Gilead.

Gilead (GILD 0.07%) will be reporting 4Q earnings on Monday, as well as the company's full 2012 results. In this video, Motley Fool health-care analyst David Williamson tells us why it has been a transformational year for the company, and what key things to watch for in the upcoming earnings report.

David Williamson has no position in any stocks mentioned. The Motley Fool recommends Gilead Sciences and Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.